Chapter 12: Three Drug Classes: Antibiotics, Analgesics, and Local Anesthetics Mod II: Analgesics, 3rd Edition 2 CE Hours Release Date: April 22, 2022 Expiration Date : April 22, 2025 Author Mark Donaldson, BSP, RPH, PharmD, FASHP, FACHE,
practitioners. Dr. Donaldson has a number of published works in the peer-reviewed literature and has co-authored several textbook chapters. He spent three years in Japan focusing on cross-cultural communication and internationalization . He currently serves on the Editorial Board for the Journal of the American Dental Association , is board certified in healthcare management, and is the past-president and past-Regent of the American College of Healthcare Executives’ Montana Chapter. Mark Donaldson has disclosed that she has no significant financial or other conflicts of interest pertaining to this course. AGD Subject Code - 134 objectives as a method to enhance individualized learning and material retention. ● Provide required personal information and payment information. ● Complete the mandatory Course Evaluation. ● Print your Certificate of Completion. Sponsorship/commercial support and non-endorsement It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
received his baccalaureate degree from the University of British Columbia (UBC) and his doctorate in clinical pharmacy from the University of Washington. He has further completed a residency at Canada’s largest tertiary care facility, Vancouver General Hospital, and i s the current Associate Principal for Vizient Pharmacy Advisory Solutions. Dr. Donaldson is a clinical professor in the Department of Pharmacy at the University of Montana in Missoula and clinical associate professor in both the School of Dentistry at the Oregon Health & Science University in Portland, Oregon, and the Faculty of Dentistry at UBC in Vancouver. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical How to receive credit ● Read the entire course online or in print. ● Depending on your state requirements you will be asked to complete: ○ A mandatory test (a passing score of 75 percent is required). Test questions link content to learning Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity. Disclaimer The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative Disclosures Resolution of conflict of interest
to diagnostic and treatment options of a specific patient’s medical condition.
©2023: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers. Learning objectives After completing this course, the learner will be able to:
Distinguish among the pharmacotherapies for neuropathic orofacial pain. Identify the currently available adjuvant pharmaceuticals for orofacial pain. Select appropriate analgesics for special populations. Oral healthcare professionals (OHCPs) are routinely involved with the selection and prescription of analgesics to address orofacial pain. In fact, dentists have been identified as the second highest prescribers of immediate-release opioids by specialty area in the United States, accounting for 12% of all prescriptions dispensed, and surpassed only by general practitioners (McCauley et al., 2016; Denisco et al., 2013). Even though opioid prescription rates for both dental surgical procedures and dental nonsurgical procedures has decreased over the past few years, the total economic burden of the opioid epidemic from 2018 through 2020 was reported to be at least $631 billion by the Society of Actuaries (Okunev, 2021; Davenport et al., 2019).
Describe the types and pathophysiology of orofacial pain. Differentiate among the pharmacotherapies for nociceptive orofacial pain. Course overview According to the Index Medicus, since publishing the second edition of this module in 2018, there have been 591 publications on, “analgesics and dentistry,” circulated in the peer-reviewed literature (https://www.ncbi.nlm.nih.gov/pubmed). This updated 2021 edition incorporates the findings of these latest research papers as well as current guidelines from regulatory and professional authorities, while continuing to emphasize the founding principles of appropriate analgesic prescribing.
EliteLearning.com/ Dental
Book Code: DHFL2624
Page 159
Powered by FlippingBook